chrisvoncsefalvay/vaers-outcomes huggingface dataset:
toothache ever since that has gotten worse/left upper dental pain; toothache ever since that has gotten worse; He is having trouble talking; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 10:20 (Lot number: EW0150) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing), notes: He takes medicine for high blood pressure. The patient took concomitant medications.  The following information was reported: TOOTHACHE (non-serious) with onset 08Apr2021 10:00, outcome "not recovered", described as "toothache ever since that has gotten worse/left upper dental pain"; CONDITION AGGRAVATED (non-serious) with onset 08Apr2021 10:00, outcome "unknown", described as "toothache ever since that has gotten worse"; COMMUNICATION DISORDER (non-serious) with onset 08Apr2021 10:00, outcome "unknown", described as "He is having trouble talking".  Additional information: No history of previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations (within 4 weeks). No patient's medical history (including any illness at time of vaccination). No relevant tests. Patient took the Pfizer Covid 19 vaccine on 7Apr2021 at 10:20 and on 08Apr2021, he developed a toothache ever since that has gotten worse/toothache in the upper left of his pallet. It is severe. The pain started on 08Apr2021 at 10:00 and has worsened through the night and is bad today. He is having trouble talking because of it. He has an appointment to see a dentist today, but he wanted to know has anyone reported a toothache when taking the vaccine. He has a dental appointment today at 11:20. He was recommended to consult with his HCP for further guidance. His physician knows nothing about this, so he hasn't contacted him. He takes medicine for high blood pressure but doesn't think it has anything to do with what he's experiencing.  No follow-up attempts are possible. No further information is expected.
Large basketball-size red, hot area near injection site. Shape was not perfectly round but with odd shifting edges and the area moved over several days to the underside of arm closer to armpit. Not really painful but very hot and slightly raised like a welt/hive. Skin was slightly stretched and then began to itch.
Information has been received from a nurse concerning a 11 year old female patient who on 04-DEC-2008 was vaccinated with GARDASIL (lot# 661530/0575X). Concomitant therapy included MENACTRA and ADACEL. She received the vaccines in the other arm the same day. On 06-DEC-2008 the patient had a slight local reaction as her arm was inflamed. The patient was given KEFLEX. No further information is available.
CDC reports: 5 yo child developed fever to 105 following DTP/OPV/MMR immunization, fever lasted 3 days.
Headache, INJECTION SITE SORENESS, FATIQUE Narrative: DAY 2-HEADACHE DAY 3 HEADACHE AND FATIQUE DAY 4 NO SYMPTOMS DAY 5 NO SYMPTOMS DAY 6-7 DULL HEADACHE DAY 11 MUSCLE ACHES AND DULL HEADACHE.
brain fog/fogginess in my head; dizziness; inability to want to do everything; lack of concentration; Waking up at 2-3 in the morning; not be getting good sleeps; depression; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "unknown", described as "brain fog/fogginess in my head"; DIZZINESS (non-serious) with onset Mar2021, outcome "unknown", described as "dizziness"; MALAISE (non-serious) with onset Mar2021, outcome "unknown", described as "inability to want to do everything"; DISTURBANCE IN ATTENTION (non-serious) with onset Mar2021, outcome "unknown", described as "lack of concentration"; MIDDLE INSOMNIA (non-serious) with onset Mar2021, outcome "unknown", described as "Waking up at 2-3 in the morning"; SLEEP DISORDER (non-serious) with onset Mar2021, outcome "unknown", described as "not be getting good sleeps"; DEPRESSION (non-serious) with onset Mar2021, outcome "unknown", described as "depression".   Additional information: Additional information: The patient reported "all went well". Doctor is giving him medication for antidepressants because his doctor thinks caller might not be getting good sleeps and questioning depression. Patient took antidepressant medication and said medication "knocked me out for hours".  The reporter stated that, "I received the shot one, a week ago today, Pfizer COVID-19 Vaccine Shot, the very first shot. I am 69 years old and extremely healthy; I don't take any medication and I have no underlying conditions. Therapeutic measures were taken as a result of depression.  No follow-up attempts are possible; information about lot/batch number cannot be obtained..
Patient came into Health Department on 06/06/2023 for her 2nd shingles vaccine. Patient was asked how she did with her first shingles vaccine that was given on 03/14/2023. Patient reported she did well and had no reactions. Administered shingles vaccine in left deltoid at 1232. Patient thanked me and left the health department. On 06/13/2023 I received a phone call from patients PCP stating patient was seen in the ER and patient thinks it was due to 2nd shingles vaccine. Patient reported her symptoms were vomiting, fever, chills, diarrhea, and blacking out. Patient?s husband called an ambulance for her. My immunization supervisor got patients ER notes faxed to us. Patient was seen in the ER on 06/07/2023 at 0719. Arrived by ambulance and chief complaint was nausea and vomiting. Patient denies SOB, chest pain, diarrhea, constipation, fever, and chills. EKG was done and no NSR was shown. Chest x-ray shows no wide mediastinum, pneumothorax, or pneumonia. Labs were drawn. Lactic acid is minimally elevated due to mild dehydration. CMP showed signs of mild dehydration. IV fluids were started. At 0915 patient reported significant improvement of her nausea and vomiting. She feels significantly better after IV fluids and is requesting to be discharged. Patient was discharged and was told to follow up with PCP in 2-3 days. Report of follow up was given to RN supervisor of the immunization department. Patient is reported to be doing better.
Cold like symptoms; However patient has a fever ranging 101.6 F/ we took my daughters temp. today and it is 101.6F; This is a spontaneous report from a contactable consumer. This consumer (patients father) parent reported for a 16-year-old female patient (reporters daughter). A 16-years-old female patient received (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number was not reported) via an unspecified route of administration on 15Apr2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patients father would like to know what the acceptable range of temperature is to get the second dose of the vaccine which was scheduled on 06May2021. The patient experienced cold like symptoms in the last few days on an unspecified date, however patient has a fever ranging 101.6 f/ we took my daughters temp. today and it is 101.6F on 06May2021. The patient underwent lab tests and procedures which included body temperature: 101.6 Fahrenheit on 06May2021.The outcome of event was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained
extreme congestion of chest;pain & swelling of arm for 1wk;extreme weakness;extreme swelling of entire arm, from shoulder to fingers;
around day 8 post vaccination, i was very itchy around the site of the vaccine. then a rash developed the next day with red bumps. size was about 2 inches x 2 inches. still see faint marking of the rash.  been more dizzy and tired than usual during the 2 weeks post-vaccination.
cold symptoms; sneezing; sinus headache; congestion face.; fever; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), MYALGIA (body aches), NASOPHARYNGITIS (cold symptoms) and SNEEZING (sneezing) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COVID-19. Concomitant products included VITAMINS NOS for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches). On 16-Mar-2021, the patient experienced NASOPHARYNGITIS (cold symptoms), SNEEZING (sneezing), SINUS HEADACHE (sinus headache) and NASAL CONGESTION (congestion face.). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Symptomatic treatment, at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE (ROBITUSSIN [DEXTROMETHORPHAN HYDROBROMIDE]) for Symptomatic treatment, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), CHILLS (chills), MYALGIA (body aches), NASOPHARYNGITIS (cold symptoms), SNEEZING (sneezing), SINUS HEADACHE (sinus headache) and NASAL CONGESTION (congestion face.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, SARS-CoV-2 test: positive (Positive) positive.         Action taken with mRNA-1273 in response to the event was not applicable.
11 X 11 cm area of induration and erythema, Right deltoid, no fever,using arm well.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, past medical history and concomitant therapies were not reported. On an unknown date since 03-JUN-2015, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # J014855 exp. date 16-APR-2016) (dose, frequency and route were not provided). No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
menstrual period started one week (7 days early); menstrual period has never started this early prior to the vaccination
Grand Mal seizure; headache; This case was reported by a consumer and described the occurrence of grand mal seizure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th March 2022, the patient received Shingles vaccine. On 25th March 2022, 1 days after receiving Shingles vaccine, the patient experienced grand mal seizure (serious criteria GSK medically significant) and headache. The patient was treated with antiepileptics nos (Seizure Medication). On an unknown date, the outcome of the grand mal seizure was unknown and the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the grand mal seizure and headache to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 30-MAR-2022 Reporter's Comments:  The patient was given the vaccine last Thursday afternoon.  The next day, in the evening, the patient had a grand mal seizure.  The patient had headaches ever since then.  The patient had a doctor's appointment on the reporting day and some tests were ordered.  The patient was on seizure medication and reported that on the questionnaire, but no one discussed the potential side effects with him/her. The reporter consented to follow up.
pt called to report 3 days post inject started w/ head cold, runny nose; had low grade fever w/aching; went to bed for 2 days; advised pt to ocntact MD & seek advise regarding next inject;
Pt recvd vax & did not know was pregnant @ the time of vax; pt had an abortion; pharmacist did not know any more details concerning the pts exp;
A report has been received from a Health Professional, concerning a 10 year old male patient. No medical history, concurrent diseases and concomitant medications were reported. On 11-Jan-2013, the patient received FLUMIST. Dosing and frequency were not reported. On 14-Jan-2013, this patient was tested positive for influenza A and the patient also presented with fever and cough. The outcome of the events of tested positive for flu A, cough and fever were unknown. The event of tested positive for flu A was considered to be non-serious by the reporter. The events of fever and cough was considered to be non-serious by the company physician.
At 7:30 pm, had sore swollen throat, tongue swollen, chest pains. Family took her to emergency room.
Friday night- nausea, HA, weak, body soreness Sat.-nausea, HA, swelling at injection site of varicella, site was red and hot to touch. Sun.- HA, nausea, flushed face, weakness, injection site red, swollen and hard. Mom states it was size of softball. Went to ER and was given antibiotics.
I had diarrhea from it, I think; was tender around where the injection was; headache; I was chilling; fever; hot to the touch; 2 inch circle that was slightly raised; I had a red area that was about size of a 2 inch circle; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot to the touch), URTICARIA (2 inch circle that was slightly raised), ERYTHEMA (I had a red area that was about size of a 2 inch circle), DIARRHOEA (I had diarrhea from it, I think) and VACCINATION SITE PAIN (was tender around where the injection was) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021H21B and 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced FEELING HOT (hot to the touch), URTICARIA (2 inch circle that was slightly raised), ERYTHEMA (I had a red area that was about size of a 2 inch circle), VACCINATION SITE PAIN (was tender around where the injection was), HEADACHE (headache), CHILLS (I was chilling) and PYREXIA (fever). On 05-Dec-2021, the patient experienced DIARRHOEA (I had diarrhea from it, I think). On 08-Dec-2021, ERYTHEMA (I had a red area that was about size of a 2 inch circle) had resolved. At the time of the report, FEELING HOT (hot to the touch), URTICARIA (2 inch circle that was slightly raised), DIARRHOEA (I had diarrhea from it, I think), HEADACHE (headache), CHILLS (I was chilling) and PYREXIA (fever) outcome was unknown and VACCINATION SITE PAIN (was tender around where the injection was) had not resolved.            No Concomitant medication was reported.     No treatment medications were reported.
I had a sinus infection following having COVID-19. I received ten days of antibiotics. The COVID-19 itself came and gone in a couple days. It wasn't that bad. The cold I experienced afterwards was worse. I never saw a doctor for COVID-19.
Chills, vomiting, fever for more than 24 hours, back aches, full body aches, headache
the patient received the correct vaccination for his age, but the vial had not been diluted when he received his shot. I contacted the father and he reported that the child was not having any symptoms.
On 9/19/01, mother called office with a complaint of rash on both legs of pt and on abdomen. He was afebrile and not acting ill. He was seen at doctor's office by NP and was told it was a reaction to MMR. On 9/20/01, phone call to mother and she said that rash was gone.
A 52-year-old female patient developed arm achiness lasting for 72 hours after receiving the intramuscular injection with a 5/8" needle of JE-VAX, dose one, lot number JEN222A (expiry date 13/May/2008) in the left deltoid on 20/Apr/2006. Per reporter patient had no illness at the time of vaccination. On 01/May/2006 the patient developed a red welt (nickel size) at the injection site. There was no fever and the area was not painful to touch. No diagnostic tests were performed. On 27/Apr/2006 the patient received the second dose of JE-VAX subcutaneously in the left upper arm. No complaints at that time. Per reporter at the time of this report the patient has not recovered. Follow-up information received on 18/May/2006 from a healthcare provider. The patient was treated with Benadryl, and "the welp went down". The event onset is provided as 01/May/2006. Follow-up information received on 21/Jul/2006. Per the reporter, the patient recovered from these adverse events. The date of recovery was not provided. No further information is expected.
Patient had both vaccines on 1-22-2010 and developed a Facial (Bell's) Palsy on 1-24-10.
Moderna COVID-19 Vaccine EUA Started at 2:30 am. Woke up absolutely freezing although the bedroom temperature was the same as always.  Could not get warm no matter how many layers I put on.  Chills along with extreme headache and body aches that wouldn't subside with either Tylenol or Motrin. Couldn't fall back asleep.   Injection site extremely painful. Couldn't put any pressure on that arm. No appetite and no energy all day.  Woke up this morning completely soaked and temperature down to 99.  Headache less painful and receptive to Tylenol. Injectiion site still sore but not as painful.
mild headache; back pain; pain in the injection site; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for herself that a female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration on an unknown date  at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. Patient experienced mild headache, back pain and pain in the injection site after the 1st vaccine. The outcome of events were unknown.  Information on the batch/Lot number has been requested.
Was slightly sore at the time of injection but went away after a day or so and then about 8 days after the administration, Injection site became very red, hot  and very itchy.   Site felt slightly harder than the other arm, redness receded gradually and arm became more pliable but after almost 2 weeks, area is still extremely itchy and still slightly reddish
Within 30 minutes of vaccine, severe chest pain, shakiness and nausea occurred.  Within an hour of vaccine got sick to the stomach and increased heartrate above 120 without lowering.  Later that evening chest pain worsened and had to be taken to the Emergency Room. Chest pain was a sharp stabbing and chest got tight.
28 weeks pregnant Arm so sore I cannot move, along with chills causing shaking uncontrollably and hot flashes. Hearing ringing or whispering around 10pm
This spontaneous report was received from a physician, via company representative, regarding an "over 15 years old" patient of unknown age. The patient's medical history, concurrent conditions, drug allergies or concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 injection (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. On an unspecified date (reported as "6 months later"), the patient received another dose of GARDASIL 9 (lot # and expiration date were unknown). No adverse effects were reported. Additional information has been requested.
Within 2 weeks of my second Pfizer COVID-19 immunization injection I started experiencing: (1) severe diahara, (2) severe constipation, (3) severe flatulency, (4) severe pain in my duodenal area. (5) severe pain in my back just behind my duodenum, (6) severe pain across my upper small intestine loop just below my rib cage starting on my right side traveling across the described path to my left side, and (7) severe pain in my shoulder. The pain has gotten worse and sometimes travels down into my large intestine intensifying at approximately the juncture of  my large intestine with my colon. I am weak and lethargic sleeping much more than normal. The pain is getting unbearable!
This spontaneous report as received from a Health care worker and refers to unspecified patients of unknown ages and genders. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On an unknown date, the patients were vaccinated with a dose of ROTATEQ orally, (which had a lot # of L035276 and an expiration date of 09-JUN-2017; however, dosage number and route of administration were not reported). Nevertheless, no adverse effects were reported. The vaccines experienced the following temperature excursions during 724 hours (30 days): 24 grades Fahrenheit. Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. Additional information has been requested.
Shots on 03/12/07. On Tues 03/13/07 there was a red hot spot about the size tennis ball on her left thigh. On Wed 03/14/07 it grew to the size of just bigger than a soft ball. Given med to see if it will help.
Patient fainted within a few minutes of receiving the injection, fell and sustained an open mandibular fracture.
Pt recvd a series of 3 Engerix-B vax & no immune response exhibited @ an appopriate interval afterwards;